BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $273,782,000 | +58.8% | 6,327,302 | +98.0% | 0.26% | -30.0% |
| Q3 2020 | $172,409,000 | -9.8% | 3,195,715 | +2.1% | 0.37% | -19.3% |
| Q2 2020 | $191,089,000 | +33.3% | 3,130,551 | +0.3% | 0.46% | -3.3% |
| Q1 2020 | $143,400,000 | -48.6% | 3,120,096 | -1.8% | 0.48% | -40.9% |
| Q4 2019 | $278,751,000 | +39.2% | 3,176,644 | +45.7% | 0.81% | +25.8% |
| Q3 2019 | $200,183,000 | +42.0% | 2,180,163 | +96.7% | 0.64% | +53.5% |
| Q2 2019 | $141,006,000 | – | 1,108,534 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |